Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 39 (RPL23AP39) is a processed pseudogene of the ribosomal protein L23a gene. It is found in the human genome but does not encode a functional protein. RPL23AP39 is not considered a protein-coding gene or a traditional therapeutic target. Unlike the parental RPL23A gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis, RPL23AP39 is a non-functional pseudogene resulting from duplication and loss of coding potential. There is currently no evidence indicating biological function, disease association, or therapeutic interaction for RPL23AP39[2][4][6]. The true ribosomal protein L23a (RPL23A) is essential for ribosome structure and function but RPL23AP39 is a pseudogene and not a direct protein product[1][7]. Processed pseudogenes like RPL23AP39 may rarely have regulatory roles, but no such role is documented for this locus[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 39 (RPL23AP39).